Home GSK's Bepirovirsen Achieves Breakthrough Functional Cure Rates, Poised to Redefine Chronic Hepatitis B Treatment

GSK's Bepirovirsen Achieves Breakthrough Functional Cure Rates, Poised to Redefine Chronic Hepatitis B Treatment

May 28, 2026 18:17 CST Updated 19:18
GSK China

Pharmaceutical Manufacturer